Alumis Reports Phase III Wins for Oral Psoriasis Pill, Analysts Unmoved
Alumis posted a set of Phase III wins for its oral psoriasis pill, yet analysts remain lukewarm on the program's commercial impact in a crowded field.
Topic
Alumis
Topic
Topic
Topic
Alumis posted a set of Phase III wins for its oral psoriasis pill, yet analysts remain lukewarm on the program's commercial impact in a crowded field.